Artwork

Content provided by Thrombosis Canada. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Thrombosis Canada or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Evaluation of definitions of OAC-associated major bleeding

22:33
 
Share
 

Manage episode 371932568 series 3495680
Content provided by Thrombosis Canada. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Thrombosis Canada or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode Dr Jameel Abdulrehman and David Airdrie are joined by Dr Yan Xu, one of the authors of a recently published review paper entitled Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study, co-authored by Yan Xu, Tara Gomes, Philip S. Wells, Priscila Pequeno, Ana Johnson, and Michelle Sholzberg. The paper was published in Thrombosis Research (Thrombosis Research 213 (2022) 57–64) available here: https://www.thrombosisresearch.com/article/S0049-3848(22)00055-X/fulltext

Dr Xu provides an overview of how the ISTH, BARC, and TIMI definitions for major bleeding on anticoagulation differ and the impact that has on research outcomes. His review explores the study results and what they may mean for future studies.
Biography:
Dr. Yan Xu, is a subspecialty fellow in Adult Thrombosis Medicine at the University of Ottawa, having completed his medical school at Queen’s University, internal medicine training at the University of Toronto and hematology fellowship at The Ottawa Hospital. Yan’s research interests involve the use of routine clinical data to better understand the safety of anticoagulant therapy, and how to optimally manage bleeding complications that arise from their use. His work has been supported by the Canadian Institutes of Health Research, the American Society of Hematology, and the CanVECTOR Network.

Thrombosis Canada Tools related to the content:

Bleed management algorithm: https://thrombosiscanada.ca/tools/?calc=vivomap271

Clinical Guide: DOACs, Management of Bleeding: https://thrombosiscanada.ca/wp-uploads/uploads/2021/11/23.-DOACs-Management-Bleeding_29November2021-1.pdf

Follow us on Twitter:
Thrombosis Canada: @ThrombosisCan
Dr Yan Xu: @IMYanXu

Reference:

Yan Xu, Tara Gomes, Philip S. Wells, Priscila Pequeno, Ana Johnson, Michelle Sholzberg, Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study, Thrombosis Research, Volume 213, 2022, Pages 57-64.

Support the show

https://thrombosiscanada.ca
Take a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

  continue reading

31 episodes

Artwork
iconShare
 
Manage episode 371932568 series 3495680
Content provided by Thrombosis Canada. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Thrombosis Canada or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode Dr Jameel Abdulrehman and David Airdrie are joined by Dr Yan Xu, one of the authors of a recently published review paper entitled Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study, co-authored by Yan Xu, Tara Gomes, Philip S. Wells, Priscila Pequeno, Ana Johnson, and Michelle Sholzberg. The paper was published in Thrombosis Research (Thrombosis Research 213 (2022) 57–64) available here: https://www.thrombosisresearch.com/article/S0049-3848(22)00055-X/fulltext

Dr Xu provides an overview of how the ISTH, BARC, and TIMI definitions for major bleeding on anticoagulation differ and the impact that has on research outcomes. His review explores the study results and what they may mean for future studies.
Biography:
Dr. Yan Xu, is a subspecialty fellow in Adult Thrombosis Medicine at the University of Ottawa, having completed his medical school at Queen’s University, internal medicine training at the University of Toronto and hematology fellowship at The Ottawa Hospital. Yan’s research interests involve the use of routine clinical data to better understand the safety of anticoagulant therapy, and how to optimally manage bleeding complications that arise from their use. His work has been supported by the Canadian Institutes of Health Research, the American Society of Hematology, and the CanVECTOR Network.

Thrombosis Canada Tools related to the content:

Bleed management algorithm: https://thrombosiscanada.ca/tools/?calc=vivomap271

Clinical Guide: DOACs, Management of Bleeding: https://thrombosiscanada.ca/wp-uploads/uploads/2021/11/23.-DOACs-Management-Bleeding_29November2021-1.pdf

Follow us on Twitter:
Thrombosis Canada: @ThrombosisCan
Dr Yan Xu: @IMYanXu

Reference:

Yan Xu, Tara Gomes, Philip S. Wells, Priscila Pequeno, Ana Johnson, Michelle Sholzberg, Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study, Thrombosis Research, Volume 213, 2022, Pages 57-64.

Support the show

https://thrombosiscanada.ca
Take a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

  continue reading

31 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide